DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $845,521 | -23.5% | 3,408 | -26.0% | 0.34% | -15.9% |
| Q2 2023 | $1,105,920 | -4.8% | 4,608 | 0.0% | 0.41% | -8.5% |
| Q1 2023 | $1,161,396 | -5.0% | 4,608 | 0.0% | 0.45% | -12.9% |
| Q4 2022 | $1,223,006 | +2.0% | 4,608 | -0.8% | 0.51% | -3.6% |
| Q3 2022 | $1,199,000 | +1.9% | 4,644 | 0.0% | 0.53% | -10.9% |
| Q2 2022 | $1,177,000 | -26.2% | 4,644 | -14.5% | 0.60% | -22.2% |
| Q1 2022 | $1,594,000 | -26.9% | 5,434 | -18.0% | 0.77% | -23.5% |
| Q4 2021 | $2,181,000 | +85.3% | 6,628 | +42.7% | 1.00% | +67.8% |
| Q2 2021 | $1,177,000 | +65.8% | 4,644 | -36.0% | 0.60% | -72.2% |
| Q1 2018 | $710,000 | +5.3% | 7,256 | 0.0% | 2.15% | +6.0% |
| Q4 2017 | $674,000 | +8.4% | 7,256 | 0.0% | 2.03% | -1.1% |
| Q3 2017 | $622,000 | +1.6% | 7,256 | 0.0% | 2.05% | -15.9% |
| Q2 2017 | $612,000 | -1.4% | 7,256 | 0.0% | 2.44% | -4.0% |
| Q1 2017 | $621,000 | +9.9% | 7,256 | 0.0% | 2.54% | +3.5% |
| Q4 2016 | $565,000 | -0.7% | 7,256 | 0.0% | 2.46% | +4.7% |
| Q3 2016 | $569,000 | -22.4% | 7,256 | 0.0% | 2.34% | -30.1% |
| Q2 2016 | $733,000 | +6.5% | 7,256 | 0.0% | 3.35% | +4.3% |
| Q1 2016 | $688,000 | -4.4% | 7,256 | -6.4% | 3.21% | -5.1% |
| Q4 2015 | $720,000 | +8.9% | 7,756 | 0.0% | 3.38% | +5.1% |
| Q3 2015 | $661,000 | -0.5% | 7,756 | 0.0% | 3.22% | +133.0% |
| Q2 2015 | $664,000 | +0.9% | 7,756 | 0.0% | 1.38% | +3.0% |
| Q1 2015 | $658,000 | -1.1% | 7,756 | 0.0% | 1.34% | +3.1% |
| Q4 2014 | $665,000 | +12.9% | 7,756 | 0.0% | 1.30% | +12.8% |
| Q3 2014 | $589,000 | -3.6% | 7,756 | 0.0% | 1.15% | +3.3% |
| Q2 2014 | $611,000 | +5.0% | 7,756 | 0.0% | 1.12% | -1.8% |
| Q1 2014 | $582,000 | -70.7% | 7,756 | -69.9% | 1.14% | -70.4% |
| Q4 2013 | $1,988,000 | +9.2% | 25,756 | -1.9% | 3.85% | -4.1% |
| Q3 2013 | $1,820,000 | -99.9% | 26,256 | 0.0% | 4.01% | +11.9% |
| Q2 2013 | $1,662,242,000 | – | 26,256 | – | 3.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |